Skip to main content
SpringerLink
Log in

A1 Milk and Heart Diseases

  • Chapter
  • First Online:
β-Casomorphins

  • 226 Accesses

Abstract

Many ecological correlations have correlated consumption of A1 milk with increased risk for incidence of CHD. These correlations are supported by human case-control studies, few in vivo and in vitro studies. It is assumed that the released BCM-7 from only A1 milk is actually the hypothetical risk element. BCMs released from A1 β-casein is proposed to play role in the progression of atherogenesis. The latter is assumed to occur through the stimulation of the oxidation of LDL by BCM-7. One of the most likely justification that cow milk β-casein could be atherogenic are the in vitro findings that demonstrated the oxidation of LDL-cholesterol to oxidized LDL-cholesterol. This biochemical finding was later validated through immunological perspective, where antibodies were assessed in infants against the oxidized LDL-cholesterol. However, few American Nutritionists, EFSA and Truswell refute all these correlations and mechanisms.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Allison AJ, Clarke AJ (2006) Further research for consideration in “the A2 milk case”. Eur J Clin Nutr 60(7):921–924

    Article  CAS  PubMed  Google Scholar 

  • Beck J, Ferrucci L, Sun K et al (2008) Circulating oxidized low-density lipoproteins are associated with overweight, obesity, and low serum carotenoids in older community-dwelling women. Nutrition 24(10):964–968

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Campbell CG, Brown BD, Dufner D et al (2006) Effects of soy or milk protein during a high-fat feeding challenge on oxidative stress, inflammation, and lipids in healthy men. Lipids 41(3):257–265

    Article  CAS  PubMed  Google Scholar 

  • Chin-Dusting J, Shennan J, Jones E et al (2006) Effect of dietary supplementation with [beta]-casein A1 or A2 on markers of disease development in individuals at high risk of cardiovascular disease. Br J Nutr 95(1):136–144

    Article  CAS  PubMed  Google Scholar 

  • Coccia R, Foppoli C, Blarzino C et al (2001) Interaction of enkephalin derivatives with reactive oxygen species. Biochim Biophys Acta 1525:43–49

    Article  CAS  PubMed  Google Scholar 

  • Crawford RA, Boland MJ, Norris CS et al (2003) Milk containing beta casein with proline at position 67 does not aggravate neurological disorders. PCT/WO 02/19832/A1

    Google Scholar 

  • Elwood PC, Pickering JE, Fehily AM et al (2004a) Milk drinking, ischaemic heart disease and ischaemic stroke I. Evidence from the Caerphilly cohort. Eur J Clin Nutr 58(5):711–717

    Article  CAS  PubMed  Google Scholar 

  • Elwood PC, Pickering JE, Hughes J et al (2004b) Milk drinking, ischaemic heart disease and ischaemic stroke II. Evidence from cohort studies. Eur J Clin Nutr 58(5):718–724

    Article  CAS  PubMed  Google Scholar 

  • Elwood PC, Strain JJ, Robson PJ et al (2005) Milk consumption, stroke, and heart attack risk: evidence from the Caerphilly cohort of older men. J Epidemiol Community Health 59(6):502–505

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Fiat AM, Levy-Tolediano S, Caen JP et al (1989) Biologically active peptides of casein and lactoferrin implicated in platelet function. J Dairy Res 56:351–355

    Article  CAS  PubMed  Google Scholar 

  • FitzGerald RJ, Meisel H (2000) Milk protein-derived peptide inhibitors of angiotensin- I-converting enzyme. Br J Nutr 84(1):33–37

    Article  Google Scholar 

  • Foltz M, Meynen EE, Bianco V et al (2007) Angiotensin converting enzyme inhibitory peptides from a lactotripeptide-enriched milk beverage are absorbed intact into the circulation. J Nutr 137(4):953–958

    Article  CAS  PubMed  Google Scholar 

  • Fontana M, Mosca L, Rosei MA (2001) Interaction of enkephalins with oxyradicals. Biochem Pharmacol 61(10):1253–1257

    Article  CAS  PubMed  Google Scholar 

  • Gómez-Ruiz J, López-Expósito I, Pihlanto A et al (2008) Antioxidant activity of ovine casein hydrolysates: identification of active peptides by HPLC–MS/MS. Eur Food Res Technol 227(4):1061–1067

    Article  CAS  Google Scholar 

  • Hartmann R, Meisel H (2007) Food-derived peptides with biological activity: from research to food applications. Curr Opin Biotechnol 18(2):163–169

    Article  CAS  PubMed  Google Scholar 

  • Hill JP, Crawford RA, Boland MJ (2002) Milk and consumer health: a review of the evidence for a relationship between the consumption of beta-casein A1 with heart disease and insulin-dependent diabetes mellitus. Proc NZ Soc Anim Prod 62:111–114

    Google Scholar 

  • Hong F, Ming L, Yi S et al (2008) The antihypertensive effect of peptides: a novel alternative to drugs? Peptides 29(6):1062–1071

    Article  CAS  PubMed  Google Scholar 

  • Korhonen H, Pihlanto A (2006) Bioactive peptides: production and functionality. Int Dairy J 16(9):945–960

    Article  CAS  Google Scholar 

  • Kritchevsky D, Tepper SA, Story JA (1988) Influence of soy protein and casein on atherosclerosis in rabbits. Fed Proc 15(3):163–169

    CAS  Google Scholar 

  • Lapointe A, Couillard C, Lemieux S (2006) Effects of dietary factors on oxidation of low-density lipoprotein particles. J Nutr Biochem 17(10):645–658

    Article  CAS  PubMed  Google Scholar 

  • Laugesen M, Elliott R (2003a) Ischaemic heart disease, type 1 diabetes, and cow milk A1 β-casein. N Z Med J 116(1168):U295

    PubMed  Google Scholar 

  • Laugesen M, Elliott R (2003b) The influence of consumption of A1 β-casein on heart disease and type 1 diabetes–the authors reply. Z Med J 116(1170):U367

    Google Scholar 

  • Lin X, Xue LY, Wang R, Zhao QY, Chen Q (2006) Protective effects of endomorphins, endogenous opioid peptides in the brain, on human low density lipoprotein oxidation. FEBS J 273(6):1275–1284

    Article  CAS  PubMed  Google Scholar 

  • Mann J, Skeaff M (2003) β-Casein variants and atherosclerosis—claims are premature. Atherosclerosis 170(1):11–12

    Article  CAS  PubMed  Google Scholar 

  • Matsuura E, Hughes GRV, Khamashta MA (2008) Oxidation of LDL and its clinical implication. Autoimmun Rev 7(7):558–566

    Article  CAS  PubMed  Google Scholar 

  • McLachlan CNS (2001) β-Casein A1, ischaemic heart disease mortality, and other illnesses. Med Hypotheses 56(2):262–272

    Article  CAS  PubMed  Google Scholar 

  • Meeker DR, Kesten HD (1941) Effect of high protein diets on experimental atherosclerosis of rabbits. Arch Pathol 31:147–162

    CAS  Google Scholar 

  • Meisel H, FitzGerald RJ (2000) Opioid peptides encrypted in intact milk protein sequences. Br J Nutr 84(1):27–31

    Article  Google Scholar 

  • Moller NP, Scholz-Ahrens KE, Roos N et al (2008) Bioactive peptides and proteins from foods: indication for health effects. Eur J Nutr 47(4):171–182

    Article  CAS  PubMed  Google Scholar 

  • Morgenstern H, Thomas D (1993) Principles of study design in environmental epidemiology. Environ Health Perspect 101(4):23–38

    PubMed  PubMed Central  Google Scholar 

  • Ness AR, Smith DG, Hart C (2002) Milk, coronary heart disease and mortality. J Epidemiol Community Health 55:379–383

    Article  Google Scholar 

  • Nicklas BJ, You T, Pahor M (2005) Behavioral treatments for chronic systemic inflammation: effects of dietary weight loss and exercise training. Can Med Assoc J 172(9):1199–1209

    Article  Google Scholar 

  • Peng X, Xiong YL, Kong B (2008) Antioxidant activity of peptide fractions from whey protein hydrolysates as measured by electron spin resonance. Food Chem 113(1):196–201

    Article  CAS  Google Scholar 

  • Saito T (2008) Antihypertensive peptides derived from bovine casein and whey proteins. Adv Exp Med Biol 606:295–317

    Article  CAS  PubMed  Google Scholar 

  • Seely S (1981) Diet and coronary disease: a survey of mortality rates and food consumption statistics of 24 countries. Med Hypotheses 7(7):907–918

    Article  CAS  PubMed  Google Scholar 

  • Steinberg D (1997) Low density lipoprotein oxidation and its pathobiological significance. J Biol Chem 272(34):20963–20966

    Article  CAS  PubMed  Google Scholar 

  • Steinberg D (2002) Atherogenesis in perspective: hypercholesterolemia and inflammation as partners in crime. Nat Med 8(11):1211–1217

    Article  CAS  PubMed  Google Scholar 

  • Stocker R, Keaney JF Jr (2004) Role of oxidative modifications in atherosclerosis. Physiol Rev 84(10):1381–1478

    Article  CAS  PubMed  Google Scholar 

  • Suetsuna K, Ukeda H, Ochi H (2000) Isolation and characterization of free radical scavenging activities peptides derived from casein. J Nutr Biochem 11(3):128–131

    Article  CAS  PubMed  Google Scholar 

  • Tailford KA, Berry CL, Thomas AC et al (2003) A casein variant in cow’s milk is atherogenic. Atherosclerosis 170(1):13–19

    Article  CAS  PubMed  Google Scholar 

  • Terpstra AHM, Harkes L, Van Der Veen FH (1981) The effect of different proportions of casein in semi purified diets on the concentration of serum cholesterol and the lipoprotein composition in rabbits. Lipids 16:114–119

    Article  CAS  PubMed  Google Scholar 

  • Torreilles J, Guerin MC (1995) Casein-derived peptides can promote human LDL oxidation by a peroxidase-dependent and metal-independent process. CR Seances Soc Biol Fil 189(5):933–942

    CAS  Google Scholar 

  • Venn BJ, Skeaff CM, Brown R et al (2006) A comparison of the effects of A1 and A2 β-casein protein variants on blood cholesterol concentrations in New Zealand adults. Atherosclerosis 188(1):175–178

    Article  CAS  PubMed  Google Scholar 

  • WHO (2003) Diet, nutrition and the prevention of chronic diseases. Report of the WHO/FAO Joint Expert Consultation WHO Technical reports 916: http://whqlibdoc.who.int/trs/WHO_TRS_916.pdf

Download references

Author information

Authors and Affiliations

  1. Department of Biochemistry, Sri Pratap College, Cluster University Srinagar, Srinagar, Jammu and Kashmir, India

    Mohammad Raies Ul Haq

Authors
  1. Mohammad Raies Ul Haq
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Ul Haq, M.R. (2020). A1 Milk and Heart Diseases. In: β-Casomorphins. Springer, Singapore. https://doi.org/10.1007/978-981-15-3457-7_6

Download citation

Publish with us

Policies and ethics

Search

Navigation